A M A Journal of Diseases of Children · 1959 · 170 citations · 10 references
FertilityGynecology4-Amino-pteroylglutamic AcidMolecular PharmacologyMaternal Pga DeficienciesPteroylglutamic AcidObstetricsReproductive MedicineMaternal NutritionPublic HealthAbortion RightsFetal DeathPlacental DevelopmentMaternal HealthMaternal-fetal MedicinePharmacologyAbortionPhysiologyMedicine
Pteroylglutamic acid (PGA, folic acid) plays an important role in many biological reactions, and PGA deficiency may lead to death of mammalian embryos. Nelson and Evans<sup>1</sup>demonstrated reproductive failure in rats kept on a PGA-deficient diet containing succinylsulfathiazole and a crude PGA antagonist. Thiersch and Philips<sup>2</sup>induced fetal death in rodents kept on an adequate diet by administration of aminopterin (4-amino-pteroylglutamic acid), a powerful PGA antagonist. Later Giroud and Lefebvres-Boisselot<sup>3</sup>and Nelson, Asling, and Evans<sup>4</sup>produced multiple congenital abnormalities by maternal PGA deficiencies during gestation. Aminopterin has also been used to induce therapeutic abortions in women with tuberculosis or cancer. In 10 out of 12 cases reported by Thiersch<sup>5</sup>oral doses of 6 to 12 mg. aminopterin induced fetal death in the first trimester of pregnancy, followed by spontaneous delivery of the products of conception. The doses lethal to the embryo had only mild effects
10